Citrafaram Life Safety
Ensuring the safety and quality of our products are our foremost considerations, The emphasis on quality is the foundation for everything we do at Citrafarm . We always keep in mind the patients who use our medicines and maintain a focus on living up to our ‘Quality Values’ every day.
We strive to continuously refine our processes and systems to deliver consistent quality Currently,. Therefore we ensure our packaging capabilities are able to keep pace and maintain the highest levels of quality and safety in this important part of the production process.
Everyone at Citrafarm Life is encouraged to ‘go beyond expectations’ in providing quality service, we are poised to expand our operations within the Middle east and Africa and Europe. Our ambition is to become a leading international pharmaceutical player.
We have learned from our experience that Quality is the most important requirement as safety and reliability come first for our customers.
This is even more true for injectable generics.
That is the reason why we made Quality the leading idea which drives our company.
We work in strict accordance to the European Good Manufacturing Practices (GMP), Good Distribution Practices (GDP), and documented Standard Operating Procedures (SOP).
Validation and qualification of our processes, in-process controls, environmental monitoring, finished product analysis, pharmacovigilance,… enable us to guarantee the highest standard
To be a leading pharmaceutical company, to carry out value-creating activities at national and international level with the specific treatment area, to be known, producing brand products, appreciated, permanent and a followed company in the pharmaceutical sector.
With the consciousness of being a well-established organization, experienced and giving the importance to human health, Pharma is growing rapidly in an efficient manner by developing and lasting its cooperation with other companies day by day.
To serve human health by prioritizing quality and safety in specific therapeutic areas.
To be a leading organization that is proud to be a member of their employees, with the priority shown to human health, while constantly updating its efficiency and development, due to legal and ethical laws.
To provide easier access to the is high-tech produced drug for not only our people but the whole world.
Using all the high-tech infrastructure of pharmaceutical industry, to develop the pharmaceutical industry and support our industry by promoting the export
Our determination to make lives better is the true essence of citrafarm and lies at the heart of everything we do. Every day we aim to pursue this goal with energy and commitment, always striving to perfect our products, services, and practices.
We are not just a pharmaceutical company, we make lives better by providing innovative, essential medicines and then working in partnership with our customers and healthcare professionals to help improve patients and deliver better outcomes for healthcare providers.
Established in 2018, Citrafarm is a fast growing Hungarian pharmaceutical company engaged in the development, , marketing and distribution of generic Parenteral injectable medicines used in hospitals
We work towards offering a wide range of high-quality injectable medicines to the hospital , clinic,pharmacy. healthcare sector worldwide , that optimises cost efficiencies whilst ensuring reliable supply.
Our strong and extensive customer base, developed through consistency of quality in products and services, has ensured sustained growth that continues to drive our ambitions to become a significant global supplier.
where we are focusing to be as a leading provider of Hospital-Medicines and with innovative and differentiated injectable products .
currently focused Europe territory, middle east , Africa, where we have an established reputation for supply and where there are clear growth opportunities for our products.
in the area of sterile injectables and oral liquids allows us to be very competitive in the supply of our hospital medicines to a wide range of countries.
Real partnership with our customers
, Citrafarm supply wide rang of medicine used in hospitals . Our product portfolio includes many injectable generic pharmaceutical formulations from several therapeutic categories including Injectable products of all forms such as Liquid injectables in glass ampoules, vials & bottles, sterile powders and freeze-dried formulations, Lyophilised products, Emulsions, Penems, Penicillins, Cephalosporins)
we partnered with well known contract manufacturing Healthcare Partners, a strategic investor with extensive
pharmaceutical expertise, to accelerate citrafarm growth. Since then, we have
enhanced our Regulatory Services team to better support our partners, and augmented
Citrafarm is a supplier of generic medicines. These are branded drugs that are manufactured according to an original brand product. This is only possible if the patent of the brand medicine has expired. Generic medicines are always cheaper than branded medicines because there are no such high costs for development and education need to be made. Generic drugs are therefore an excellent way to realize cost savings in health care while maintaining quality .Citrafarm has an extensive range of generic medicines and we deliver these through pharmaceutical wholesalers to pharmacies, hospitals .
Citrafarm is a supplier of high quality sterile generic injectables to the hospital market
Our company has strong ties with many local and international pharmaceutical distributors, manufacturers and with full line wholesalers. Through our established and validated networks of suppliers we can source, store and supply a wide variety of Pharmaceutical products. We supply direct to market covering pharmacies, , , overseas public and private sector hospitals, after-care markets, healthcare authorities, Ministries of Health .
Our goal is to become a leader in generic injectable products. , we are investing heavily to expand our operations, enhance our scientific personnel, and to pursue new partnerships and product acquisitions. We are confident that Citrafarm will dramatically increase its role in bringing important generic injectable products to market
